Medical Cannabis for Huntington’s Disease: A Complete Patient & Caregiver Resource Guide

Huntington’s disease affects movement, thinking, emotional health, and daily independence in ways that can feel overwhelming for both patients and families. As symptoms progress, many people explore supportive therapies to improve comfort, sleep, stress levels, appetite, and overall quality of life.  Some patients discuss medical marijuana treatment as part of broader conversations about symptom management alongside standard neurological care. This guide explains how medical cannabis may fit into Huntington’s disease support, what limitations patients should understand, and how to approach cannabis use carefully, realistically, and safely over time.

1. Welcome: Understanding This Guide

1.1 Who This Guide Is For

This guide is for people living with Huntington’s disease, caregivers, family members, and partners seeking practical information about medical cannabis. It focuses on symptom support, safety, quality of life, and informed decision making. The guide explains potential benefits and limitations while encouraging continued neurological care and open communication with healthcare professionals.

1.2 Why some HD patients consider medical cannabis

People living with Huntington’s disease may experience symptoms that affect comfort, emotional well-being, appetite, sleep, and daily functioning. Some patients explore cannabis because certain products may help them relax, feel more comfortable physically, or rest more easily at night. Patients commonly discuss cannabis for concerns such as:

• Movement-related discomfort or restlessness
• Anxiety, irritability, or emotional stress
• Sleep disruption and nighttime symptoms
• Appetite changes or weight loss
• Overall quality of life support

Responses vary from person to person, which is why product selection, careful dosing, and medical guidance remain important when considering cannabis use in Huntington’s disease.

1.3 What this guide can and cannot do

This guide explains how cannabis may support symptom management and comfort for some Huntington’s disease patients. It does not claim cannabis cures Huntington’s disease, reverses brain degeneration, or stops disease progression entirely. Huntington’s disease remains a complex neurodegenerative condition that still requires ongoing neurological care and supportive treatment. Patients and caregivers should also be cautious about websites or products promising brain healing, genetic reversal, or miracle cures through cannabis alone. Responsible cannabis use means keeping realistic expectations while focusing on symptom support, safety, and quality of life alongside broader medical care.

2. Huntington’s Disease Basics Every Family Should Understand

2.1 What Huntington’s disease is

Huntington’s disease is a hereditary neurodegenerative disorder that affects movement, thinking, emotional health, and daily functioning over time. It develops due to a mutation in the HTT gene, which gradually damages nerve cells in specific parts of the brain. According to a 2023 overview from the National Institute of Neurological Disorders and Stroke, Huntington’s disease is an inherited brain disorder that causes progressive changes involving movement, cognition, and psychiatric health over time.  Symptoms often begin gradually and may include involuntary movements, mood changes, irritability, slowed thinking, memory problems, or difficulty with coordination. Because Huntington’s disease affects multiple areas of brain function, patients and families often face both physical and emotional challenges as the condition progresses.

2.2 How HD affects the brain over time

As Huntington’s disease progresses, brain changes may affect motor control, cognition, mood regulation, speech, swallowing, and decision making. Symptoms often change gradually over many years, though progression varies among individuals and families. Families may notice changes involving:

• Involuntary movements or restlessness
• Slower thinking and concentration problems
• Anxiety, depression, or irritability
• Difficulty organizing daily activities
• Changes in speech or swallowing

These symptoms are caused by neurological changes in the brain and should not be viewed as laziness, personality weakness, or intentional behavior.

2.3 Early, middle, and advanced stages of HD

Early-stage Huntington’s disease may involve mild coordination problems, emotional changes, sleep disruption, or subtle movement symptoms that interfere with work and daily routines. Many patients still remain largely independent during this stage while beginning to adjust to diagnosis and long-term planning. Middle and advanced stages may involve worsening movement difficulties, falls, swallowing problems, changes in communication, and increased dependence on caregivers. Families often need growing levels of emotional, medical, and practical support as symptoms progress. Quality of life, safety, comfort, and caregiver well-being all become increasingly important parts of long-term Huntington’s disease care.

3. The Genetics of Huntington’s Disease

3.1 Understanding the inherited nature of HD

Huntington’s disease is caused by a mutation in the HTT gene, which is inherited in an autosomal dominant pattern. This means a child of a parent with Huntington’s disease has a 50 percent chance of inheriting the gene mutation. Families often experience emotional stress not only from symptoms themselves, but also from uncertainty about future generations. Because Huntington’s disease is hereditary, diagnosis may affect siblings, children, cousins, and extended family members differently. Some people choose genetic testing early, while others prefer not to know their status immediately. Families often benefit from counseling, education, and support as they navigate these deeply personal decisions.

3.2 Predictive genetic testing

Predictive genetic testing allows individuals with a family history of Huntington’s disease to learn whether they carry the gene mutation before symptoms appear. This decision can feel emotionally complex because results may affect relationships, future planning, mental health, and long-term life choices. People considering testing often discuss concerns such as:

• Emotional readiness for results
• Family planning decisions
• Career and financial planning
• Insurance and long-term care concerns
• Anxiety about future symptoms

Genetic counseling is strongly encouraged before and after testing because emotional support and accurate information are important parts of the process.

3.3 Family planning and future concerns

Huntington’s disease can significantly affect long-term family planning. Some individuals worry about passing the gene mutation to children, while others face difficult decisions involving caregiving responsibilities, finances, housing, or future medical care needs. Families may also need to gradually prepare for changing levels of independence as symptoms progress. Open communication, emotional support, legal planning, and professional guidance can help reduce stress and improve long-term stability. While these conversations may feel difficult, early planning often helps families feel more prepared and supported moving forward.

4. Current Medical Treatments for Huntington’s Disease

4.1 Medications used in HD care

There is currently no cure for Huntington’s disease, but several medications may help manage symptoms affecting movement, mood, sleep, irritability, depression, and psychiatric health. Some drugs are prescribed specifically to reduce chorea, while others target anxiety, insomnia, emotional instability, or behavioral symptoms. Medication responses vary greatly between patients, and treatment plans often change over time as symptoms evolve. Some individuals tolerate medications well, while others experience fatigue, sedation, emotional blunting, or movement-related side effects. Ongoing neurological care helps patients and caregivers adjust treatment safely as needs change.

4.2 Therapies beyond medication

Supportive therapies often play a major role in helping Huntington’s disease patients maintain safety, communication, mobility, and quality of life. Physical therapy may help support balance and movement, while occupational therapy can improve daily functioning and home safety. Patients commonly benefit from supportive care such as:

• Physical therapy for mobility and fall prevention
• Occupational therapy for daily activities
• Speech therapy for communication and swallowing
• Mental health counseling and emotional support
• Nutrition guidance and caregiver education

Combining therapies often helps patients maintain independence and comfort longer as symptoms progress.

4.3 Where cannabis may fit into treatment

Some Huntington’s disease patients explore cannabis as part of a broader symptom support plan alongside neurological care and standard treatment. Certain products may help some individuals feel calmer, sleep more comfortably, improve appetite, or reduce stress connected to chronic illness. Many families are interested in cannabis because improving comfort and quality of life can make daily routines feel more manageable over time. According to a 2022 chapter review published by IntechOpen, researchers continue studying the endocannabinoid system in Huntington’s disease because cannabis based therapies may potentially support symptom management and quality of life in some patients, although more research is still needed.  Cannabis should support overall care rather than replace medical treatment or therapy. Responsible use involves careful dosing, product safety, symptom tracking, and ongoing communication with healthcare professionals familiar with neurological disease and medication interactions.

5. Can Medical Cannabis Treat Huntington’s Disease?

5.1 What cannabis may help with

Some Huntington’s disease patients explore cannabis because certain products may help support relaxation, sleep, appetite, emotional comfort, or overall quality of life. Patients dealing with stress, nighttime restlessness, reduced appetite, or muscle discomfort sometimes report feeling more comfortable when cannabis is used carefully as part of broader supportive care. Cannabis affects every patient differently, depending on product type, THC strength, overall health, and symptom severity. While some people experience meaningful symptom relief, others may notice little benefit or need adjustments in product selection and dosing. Careful monitoring remains especially important in Huntington’s disease because balance, cognition, and coordination may already be affected.

5.2 What cannabis cannot do

Cannabis does not cure Huntington’s disease, reverse brain degeneration, or stop the genetic mutation responsible for the condition. Current research has not shown that cannabis can prevent disease progression or restore damaged nerve cells in the brain. Patients and caregivers should remember:

• Cannabis is not a cure for Huntington’s disease
• It cannot reverse neurological damage
• It does not replace neurological care
• Symptom responses vary between patients
• Standard medical treatment still remains important

Responsible cannabis use focuses on symptom support, comfort, and quality of life rather than expecting dramatic neurological recovery.

5.3 Avoiding misleading “brain healing” claims

Families affected by Huntington’s disease may feel vulnerable to online marketing promising brain healing, genetic repair, or natural neurodegenerative disease cures. Products claiming cannabis can fully reverse Huntington’s disease or rebuild damaged brain tissue should be viewed very cautiously. Reliable cannabis education focuses on symptom management and realistic expectations instead of miracle cure promises. Patients benefit most from regulated products, evidence-based medical care, and open discussions with healthcare professionals, rather than from aggressive online marketing or unsupported health claims.

6. Symptoms that Huntington’s Patients Often Seek Cannabis For

6.1 Movement symptoms and muscle discomfort

Movement symptoms in Huntington’s disease may include chorea, muscle tension, restlessness, stiffness, and involuntary movements, as well as physical discomfort that interferes with sleep and daily activities. Some patients explore cannabis because certain products may help them feel more physically relaxed or less tense during difficult periods. Responses vary significantly between individuals. Some patients report feeling calmer and more comfortable physically, while others may experience worsening balance or sedation with stronger THC products. Careful dosing and symptom tracking are especially important because Huntington’s disease already affects coordination and mobility over time.

6.2 Anxiety, irritability, and emotional distress

Huntington’s disease often affects emotional regulation as well as movement. Patients may experience anxiety, irritability, frustration, mood instability, or emotional exhaustion connected to both neurological changes and the stress of living with chronic illness. According to a 2021 review published in Frontiers in Psychiatry, some patients using medical cannabis report improvements in stress, relaxation, emotional tension, and overall mood-related symptoms, although responses may vary between individuals and product types. Patients commonly discuss cannabis for concerns such as:

• Anxiety and emotional tension
• Irritability and restlessness
• Sleep disruption linked to stress
• Difficulty relaxing at night
• Overall emotional well-being support

Some individuals report that carefully selected cannabis products help them feel calmer or emotionally more balanced, particularly when products are introduced gradually and used responsibly alongside broader emotional support strategies.

6.3 Sleep problems and appetite changes

Sleep disruption and reduced appetite are common quality-of-life concerns in Huntington’s disease. Movement symptoms, anxiety, medication side effects, and neurological changes may all interfere with restful sleep and regular eating patterns. Some patients explore cannabis because certain products may help support relaxation, nighttime comfort, or appetite during stressful periods. However, symptom monitoring remains important because excessive sedation, confusion, or poor coordination may increase safety risks in certain individuals, especially as disease progression advances.

7. Understanding THC, CBD, and Other Cannabinoids

7.1 THC explained

THC is the primary intoxicating cannabinoid found in cannabis. It produces the feeling of being high and may affect mood, relaxation, appetite, sleep, coordination, and perception. Some Huntington’s disease patients explore THC products because certain doses may help support relaxation, emotional comfort, or nighttime symptom management. However, THC may also affect concentration, reaction time, balance, and memory, especially at higher doses. Patients with Huntington’s disease should approach THC carefully because movement symptoms and coordination problems may already increase fall risk. Many patients benefit from starting with low doses and gradually increasing them rather than choosing highly concentrated products immediately.

7.2 CBD explained

CBD is a non-intoxicating cannabinoid that many patients associate with calming effects and symptom support without the strong intoxication linked to THC. Some Huntington’s disease patients explore CBD products for stress, emotional balance, sleep support, or general relaxation as part of broader symptom management. Patients considering CBD should remember:

• CBD may still interact with medications
• Product quality varies widely
• Some CBD products contain THC
• Higher doses may increase drowsiness
• Medical guidance remains important

CBD is often viewed as more approachable for patients sensitive to THC, although responses still vary significantly between individuals.

7.3 Minor cannabinoids and terpenes

Minor cannabinoids such as CBG and CBN, along with aromatic compounds called terpenes, are increasingly discussed in cannabis products marketed for sleep, relaxation, or focus. Research involving these compounds remains limited, and many claims still lack strong clinical evidence in Huntington’s disease specifically. Patients should approach heavily marketed products cautiously, especially products promising dramatic neurological improvement based on terpene blends or uncommon cannabinoids. Regulated products with transparent labeling and realistic claims are generally safer choices for patients managing neurological disease and multiple medications.

8. Potential Benefits of Cannabis in Huntington’s Disease

8.1 Relaxation and stress reduction

Living with Huntington’s disease may create ongoing physical and emotional stress for both patients and caregivers. Movement symptoms, uncertainty about progression, changing independence, and daily frustrations can all contribute to tension and emotional exhaustion. Some patients report that carefully selected cannabis products help them feel calmer and physically more relaxed during stressful periods. Relaxation support may improve overall quality of life for certain individuals by helping reduce emotional tension and improving nighttime comfort. However, responses vary greatly between patients, and careful dosing remains important because excessive THC may worsen confusion or instability in some individuals.

8.2 Sleep and nighttime symptom support

Sleep problems are common in Huntington’s disease and may involve restlessness, nighttime movements, anxiety, or difficulty falling asleep. Some patients explore cannabis because certain products may help support relaxation and improve nighttime comfort. Patients often discuss cannabis for nighttime concerns, such as:

• Difficulty falling asleep
• Frequent nighttime waking
• Physical restlessness at night
• Anxiety interfering with sleep
• Poor sleep quality and fatigue

Many patients find symptom support works best when cannabis is combined with healthy sleep routines, stress management, and ongoing neurological care.

8.3 Appetite and weight support

Weight loss and reduced appetite are common concerns in Huntington’s disease, partly because involuntary movements may increase calorie expenditure throughout the day. Some patients also experience swallowing problems, reduced interest in food, or emotional stress that affects eating habits. According to a 2025 review published in Current Nutrition Reports, unintended weight loss and nutritional challenges are common in Huntington’s disease because increased energy expenditure, swallowing difficulties, and neurological changes may all affect food intake and body weight over time.  Certain THC products may help stimulate appetite or improve the enjoyment of meals for some individuals. Supporting nutrition and calorie intake may help patients maintain strength, energy, and overall well-being as symptoms progress.

9. Risks and Side Effects HD Patients Need to Understand

9.1 Balance, falls, and coordination risks

Huntington’s disease already affects balance, coordination, and movement control, which means patients may be more sensitive to the physical effects of cannabis. Higher THC products may increase dizziness, slowed reaction time, or unsteadiness in some individuals, especially when standing, walking, or changing positions quickly. This does not mean cannabis is automatically unsafe for every Huntington’s disease patient. Many individuals tolerate carefully selected products well when doses are introduced slowly and monitored responsibly. Families often focus on finding lower doses and balanced products that support comfort while still allowing patients to remain alert and steady during daily activities.

9.2 Cognitive and memory concerns

Huntington’s disease may gradually impair concentration, planning, memory, and mental processing. THC products may also temporarily affect focus or reaction time, particularly at stronger doses. As a result, patients often benefit from careful symptom tracking and gradual dose adjustments. Patients and caregivers should pay attention to changes such as:

• Increased confusion or forgetfulness
• Difficulty following conversations
• Slower reaction time during activities
• Excessive daytime sedation
• Worsening focus during daily routines

Many patients still use cannabis successfully by choosing regulated products, lower doses, and symptom goals focused on comfort and quality of life.

9.3 Anxiety, paranoia, and psychiatric symptoms

Some Huntington’s disease patients experience anxiety, depression, irritability, or emotional instability as part of the disease itself. While certain cannabis products may help some individuals feel calmer or emotionally more comfortable, stronger THC products may occasionally increase anxiety or emotional discomfort in sensitive patients. Responsible cannabis use involves paying close attention to emotional well-being and adjusting products when needed. Patients with significant psychiatric symptoms often benefit from ongoing neurological and mental health support alongside any cannabis use discussions to help maintain safety, stability, and quality of life.

10. Cannabis and Huntington’s Disease Medications

10.1 Why interactions matter

Many Huntington’s disease patients take medications for movement symptoms, sleep problems, anxiety, depression, or psychiatric concerns. THC and CBD are processed by liver enzymes, which may also affect how certain medications work in the body. According to a 2022 review published in Frontiers in Psychiatry, cannabinoids such as THC and CBD may interact with medications metabolized through liver enzyme pathways, which is why monitoring and medical guidance remain important when cannabis is used alongside prescription treatments.  This does not automatically mean cannabis is unsafe, but it does mean careful monitoring matters. Some combinations may increase drowsiness, dizziness, slowed thinking, or coordination problems. Open communication with healthcare professionals can help patients and caregivers make safer decisions when adding cannabis to an existing treatment plan. 

10.2 Sedation and safety concerns

Certain Huntington’s disease medications already cause fatigue or sedation, particularly medications used for sleep, mood stabilization, or chorea management. Cannabis may increase these calming effects in some individuals, especially when higher THC products are combined with sedating prescriptions. Patients and caregivers often watch closely for concerns such as:

• Excessive daytime sleepiness
• Increased fall risk
• Slowed reactions or confusion
• Difficulty waking up fully
• Reduced alertness during meals or walking

Many patients still use cannabis safely by starting with low doses, choosing carefully regulated products, and adjusting slowly over time.

10.3 Questions to ask your neurologist or pharmacist

Patients should feel comfortable discussing cannabis openly with neurologists, pharmacists, and healthcare providers involved in Huntington’s disease care. Honest conversations help providers monitor interactions, side effects, and symptom changes more effectively. Helpful questions may include whether cannabis could increase sedation, interfere with medication timing, worsen coordination, or require additional monitoring. Patients may also ask about safer product types, balanced THC and CBD ratios, and realistic symptom goals based on their stage of Huntington’s disease and overall health.

11. Cannabis and Chorea: What Patients Should Know

11.1 Understanding involuntary movements

Chorea is one of the most recognizable movement symptoms of Huntington’s disease. These involuntary movements may affect the arms, legs, face, posture, speech, and walking patterns. Some movements appear mild and restless, while others interfere with balance, eating, communication, or daily tasks over time. Movement symptoms can also create emotional frustration and physical exhaustion for both patients and caregivers. Some individuals experience muscle tension, restlessness, or discomfort related to constant involuntary movement. Because chorea affects patients differently, symptom management often requires ongoing adjustments involving medications, therapy, safety planning, and supportive care strategies.

11.2 What current research suggests

Research involving cannabis and chorea in Huntington’s disease remains limited and sometimes inconsistent. Even so, many patients and researchers remain interested in cannabinoids because some individuals report improvements involving relaxation, sleep, physical comfort, and overall quality of life while using carefully selected cannabis products. According to a 2022 review published in Frontiers in Computational Neuroscience, researchers continue to study the endocannabinoid system in Huntington’s disease because cannabinoids may influence neurological pathways involved in movement control, the stress response, and symptom regulation. Current research discussions often focus on areas such as:

• Relaxation and stress support
• Sleep improvement
• Muscle tension and discomfort
• Emotional wellbeing
• Overall quality of life

While stronger clinical evidence is still needed, ongoing research continues to encourage interest in how cannabis may support symptom management and comfort for some Huntington’s disease patients.

11.3 Realistic expectations for symptom relief

Patients and caregivers should approach cannabis with realistic expectations, especially regarding chorea itself. Cannabis may help some individuals feel more relaxed or physically comfortable, but most patients do not experience a dramatic elimination of involuntary movements. Responsible cannabis use focuses more on comfort, stress reduction, appetite support, sleep quality, and overall quality of life rather than expecting major neurological reversal. Many families find the most helpful approach involves combining symptom-support strategies with ongoing neurological care and safety monitoring.

12. Anxiety, Irritability, and Emotional Symptoms in HD

12.1 Emotional changes are part of the disease

Huntington’s disease affects both emotional regulation and physical movement. Patients may experience anxiety, depression, irritability, impulsive behavior, frustration, or emotional withdrawal because of neurological changes happening within the brain. These symptoms are medical and neurological in nature, not personal weakness or intentional behavior. Families sometimes struggle to separate disease-related emotional changes from personality traits, especially during stressful situations. Understanding that emotional symptoms are part of Huntington’s disease may help reduce blame, improve communication, and encourage patients to seek emotional support earlier.

12.2 Cannabis and emotional regulation

Some Huntington’s disease patients explore cannabis because certain products may help support relaxation, emotional balance, or nighttime calmness during periods of stress and irritability. Carefully selected products may help some individuals feel less emotionally overwhelmed and more physically relaxed. Patients considering cannabis for emotional symptoms should still pay attention to factors such as:

• THC strength and overall dose
• Changes in mood or irritability
• Anxiety or paranoia after use
• Sleep quality and daily functioning
• Interaction with psychiatric medications

Many patients tolerate carefully managed cannabis use well, especially when products are introduced slowly and monitored honestly over time.

12.3 Building emotional support systems

Emotional support remains one of the most important parts of Huntington’s disease care for both patients and caregivers. Counseling, support groups, structured routines, social connection, and caregiver education may all improve emotional stability and reduce feelings of isolation. Cannabis may support relaxation for some individuals, but long-term emotional well-being usually depends on broader support systems and ongoing communication. Families often benefit from building care teams that include neurologists, mental health professionals, therapists, and trusted support networks as symptoms progress.

13. Sleep Problems and Fatigue in Huntington’s Disease

13.1 Why sleep disruption is common

Sleep problems are very common in Huntington’s disease and may develop for several different reasons at the same time. Movement symptoms, anxiety, nighttime restlessness, medication side effects, emotional stress, and neurological changes within the brain may all interfere with restful sleep patterns. Poor sleep can also worsen irritability, concentration problems, daytime fatigue, and emotional strain for both patients and caregivers. Some individuals struggle to fall asleep, while others wake frequently during the night due to movement, discomfort, or confusion. Understanding the causes of sleep disruption may help families build more effective symptom-management routines over time.

13.2 Cannabis for sleep support

Some Huntington’s disease patients explore cannabis because certain products may help support relaxation and nighttime comfort. Carefully selected products may help some individuals settle more easily at night or reduce stress connected to insomnia and nighttime restlessness. According to a 2023 systematic review published in Cannabis and Cannabinoid Research, many studies reported improvements in insomnia symptoms and sleep quality in at least some patients using cannabinoid based therapies, particularly products containing both THC and CBD. Patients often discuss cannabis for concerns such as:

• Difficulty falling asleep
• Frequent nighttime waking
• Physical restlessness at night
• Anxiety affecting sleep quality
• Daytime fatigue linked to poor sleep

Many patients find the best results come from gradual dosing, careful symptom tracking, and combining cannabis with healthy sleep habits rather than relying on stronger THC products alone.

13.3 Healthy sleep habits still matter

Even when cannabis helps support nighttime comfort, healthy sleep habits still play an important role in long-term wellbeing. Irregular schedules, caffeine late in the day, stress, excessive screen time, and poor sleep environments may all worsen sleep disruption over time. Patients often benefit from consistent bedtime routines, calming evening environments, stress reduction techniques, and regular communication with healthcare providers about sleep concerns. Sleep support usually works best when cannabis is combined with broader lifestyle and medical strategies focused on comfort and stability.

14. Appetite, Weight Loss, and Nutrition

14.1 Why HD patients often lose weight

Weight loss is common in Huntington’s disease because involuntary movements may significantly increase calorie expenditure throughout the day. Some patients also experience swallowing difficulties, reduced appetite, fatigue, depression, or stress that makes eating feel more difficult or exhausting over time. Maintaining weight becomes increasingly important because poor nutrition may affect strength, energy, immune function, and overall quality of life. Families often need to adjust meal timing, food texture, and calorie intake as symptoms progress and nutritional needs change.

14.2 Cannabis and appetite stimulation

Some Huntington’s disease patients explore cannabis because THC may help stimulate appetite or improve the enjoyment of meals. Patients dealing with reduced food intake or weight loss sometimes report that certain products make eating feel easier or more appealing during stressful periods. Patients commonly use cannabis to support concerns such as:

• Reduced appetite during illness progression
• Difficulty maintaining weight
• Low interest in food
• Stress affecting eating habits
• Fatigue connected to poor nutrition

Cannabis may help support appetite for some individuals, although responses vary greatly depending on product type, dose, and overall health.

14.3 Nutrition strategies beyond cannabis

Nutrition support in Huntington’s disease usually involves much more than appetite stimulation alone. Many patients benefit from calorie-dense meals, protein-rich snacks, smoothies, hydration support, and softer foods that are easier to swallow safely. Dietitians and healthcare professionals may also help families develop meal strategies that support changing energy needs and swallowing safety over time. Cannabis may help support appetite for some patients, but long-term nutrition planning still remains an important part of overall Huntington’s disease care.

15. Swallowing Problems and Cannabis Safety

15.1 Dysphagia in Huntington’s disease

Swallowing difficulties, also called dysphagia, are common in Huntington’s disease and often become more noticeable as symptoms progress. Patients may cough during meals, choke more easily, struggle with chewing, or have difficulty controlling food and liquids safely while swallowing. Dysphagia can increase the risk of dehydration, poor nutrition, choking, and aspiration, which occurs when food or liquid enters the airway instead of the stomach. Because swallowing problems may develop gradually, families sometimes notice subtle warning signs before recognizing how serious the issue has become. Early evaluation and speech therapy support may help improve safety and meal planning.

15.2 Choosing safer cannabis forms

Patients with swallowing difficulties may need to avoid certain cannabis products that increase choking risk. Large gummies, hard candies, dry edibles, or products requiring strong chewing may become difficult or unsafe as dysphagia progresses. Patients and caregivers often discuss safer options such as:

• Tinctures placed under the tongue
• Measured cannabis oils
• Softer edible products when appropriate
• Carefully monitored capsule use
• Non-inhaled products with simpler dosing

Product selection should always consider swallowing ability, coordination, alertness, and overall safety rather than convenience alone.

15.3 Caregiver monitoring during meals and medication use

Caregivers often play an important role in monitoring swallowing safety during meals, medication routines, and cannabis use. Watching for coughing, choking, excessive sedation, or difficulty staying alert during eating may help identify safety concerns early. Patients using sedating cannabis products may require additional supervision during meals if alertness or coordination becomes affected. Open communication with neurologists, speech therapists, and healthcare providers may help families adjust routines and product choices more safely as swallowing symptoms change over time.

16. Choosing Safer Cannabis Products

16.1 Why tested products matter

Product quality matters greatly for Huntington’s disease patients because contaminated or inaccurately labeled cannabis products may create unnecessary health and safety risks. Regulated products are generally tested for potency, pesticides, mold, heavy metals, and contaminants that may affect vulnerable patients more seriously. Patients managing neurological symptoms often benefit from predictable dosing and transparent labeling. Reliable products make it easier for caregivers and healthcare providers to track symptom response and adjust dosing carefully over time.

16.2 Understanding product labels

Cannabis labels may feel confusing at first, especially for patients and caregivers unfamiliar with THC percentages, CBD content, serving sizes, or cannabinoid ratios. Learning how to read labels carefully may help families choose products more safely and avoid accidental overconsumption. Important label details often include:

• THC and CBD amounts per serving
• Serving size recommendations
• Ingredient lists and additives
• Batch numbers and testing dates
• Expiration information

Understanding labels may help patients choose products that are better aligned with their symptom goals and comfort levels.

16.3 Products to avoid

Patients and caregivers should avoid products with unclear ingredients, unrealistic medical claims, or no reliable testing information. Unknown vape cartridges, synthetic cannabinoids, and heavily marketed miracle cure products may carry additional safety risks for Huntington’s disease patients. Products claiming to reverse brain degeneration or cure Huntington’s disease naturally should be approached very cautiously. Safer cannabis use begins with regulated products, realistic expectations, careful dosing, and open communication with healthcare professionals familiar with neurological disease management.

17. Methods of Use: Smoking, Edibles, Tinctures, and More

17.1 Inhaled cannabis

Inhaled cannabis includes smoking and vaporized products that enter the bloodstream quickly through the lungs. Many Huntington’s disease patients prefer inhalation because effects are often felt within minutes, making it easier to adjust doses gradually and respond to symptoms more predictably. Some individuals report that inhaled products help them relax more quickly during periods of stress, nighttime restlessness, or physical discomfort. However, inhaled cannabis may not be ideal for every patient. Smoking may irritate the lungs, especially in individuals with respiratory concerns or long histories of tobacco use. Patients with balance problems or coordination difficulties should also approach stronger inhaled THC products carefully because effects may appear rapidly and feel more intense than expected.

17.2 Edibles and capsules

Edibles and capsules work differently because cannabinoids pass through the digestive system before entering the bloodstream. Effects usually take longer to appear compared to inhaled products, but they may also last much longer. Some Huntington’s disease patients prefer edibles for nighttime symptom support or longer periods of relaxation and comfort. Patients and caregivers should still approach edibles cautiously because delayed onset may increase the risk of accidentally taking too much. Patients often consider factors such as:

• Slower onset compared to inhaled products
• Longer-lasting effects
• Easier nighttime symptom support
• Greater importance of careful dosing
• Increased risk of delayed overconsumption

Starting with very low doses and waiting patiently before taking more may help reduce unpleasant experiences and improve safety.

17.3 Oils, tinctures, and topicals

Tinctures and oils are commonly placed under the tongue or swallowed, depending on the product. Some Huntington’s disease patients prefer these options because they may offer more precise dosing and easier administration for caregivers. Topicals are applied directly to the skin and are generally used for localized discomfort rather than whole-body effects. Different methods affect patients differently depending on symptom goals, swallowing ability, timing preferences, and overall health. Many families find that carefully tested products, gradual dosing, and open communication with healthcare providers help create safer and more comfortable symptom management routines over time.

18. Dosing Principles for Huntington’s Disease Patients

18.1 Start low and go slow

Huntington’s disease patients often benefit from starting with very low cannabis doses and increasing gradually only when needed. This approach is especially important because movement symptoms, balance problems, and cognitive changes may already affect daily functioning before cannabis is introduced. Some patients tolerate low doses comfortably and report improvements in relaxation, appetite, or nighttime comfort without significant impairment. Starting slowly also gives patients and caregivers time to observe how products affect coordination, alertness, emotional wellbeing, and daily routines before adjusting product strength or frequency.

18.2 Tracking effects carefully

Tracking symptom response may help patients and caregivers understand which products support comfort without creating unnecessary side effects. Keeping notes about movement symptoms, sleep quality, appetite, mood, and alertness may make treatment discussions more productive over time. Helpful things families often track include:

• Product type and cannabinoid content
• Dose amount and timing
• Sleep quality and nighttime symptoms
• Appetite and meal intake
• Changes in balance, mood, or coordination

Symptom tracking may help caregivers and healthcare professionals identify patterns more clearly and make safer dosing adjustments over time.

18.3 Signs a dose may be too high

Patients should reduce or pause cannabis use if products begin causing more problems than benefits. Higher THC doses may increase confusion, panic, dizziness, excessive sedation, or worsening instability in certain Huntington’s disease patients. Falls, worsening coordination, emotional withdrawal, or significant daytime sleepiness may all signal that adjustments are needed. Responsible cannabis use focuses on improving comfort and quality of life while still supporting safety, communication, mobility, and overall daily functioning for both patients and caregivers.

19. Cognitive Decline and Cannabis Use

19.1 Understanding cognitive changes in HD

Huntington’s disease gradually affects more than movement alone. Many patients also experience changes involving memory, concentration, planning, judgment, multitasking, and decision-making over time. These cognitive changes may appear slowly and can affect work, finances, communication, medication routines, and overall independence long before severe physical symptoms develop. Families sometimes misunderstand these changes and assume the patient is becoming careless, unmotivated, or inattentive. In reality, cognitive symptoms are part of the neurological progression of Huntington’s disease. Understanding this may help caregivers respond with more patience, structure, and support while reducing unnecessary conflict or frustration during daily routines.

19.2 How THC may affect cognition

THC may temporarily affect concentration, reaction time, short term memory, and mental processing, especially at higher doses. Because Huntington’s disease may already affect cognition, some patients are more sensitive to stronger THC products than others. Patients and caregivers often monitor for changes such as:

• Increased confusion or forgetfulness
• Difficulty staying focused on conversations
• Slower reaction time during daily tasks
• Excessive sedation or mental fog
• Problems following medication schedules

Many patients still tolerate carefully managed cannabis use well, especially when products are introduced gradually, and symptom goals remain focused on comfort, sleep, or relaxation rather than heavy intoxication.

19.3 Caregiver involvement in cannabis decisions

Caregivers often play an important role in helping Huntington’s disease patients use cannabis more safely as cognitive symptoms progress. Monitoring doses, tracking symptom changes, organizing medications, and observing behavior patterns may help reduce confusion and improve safety over time. Open communication between patients, caregivers, and healthcare professionals may help families make more informed decisions about product types, dosing routines, and long term symptom management goals. Responsible cannabis use works best when safety, quality of life, and emotional well-being remain central parts of the conversation.

20. Advanced Huntington’s Disease and Cannabis Considerations

20.1 Late-stage symptom challenges

Advanced Huntington’s disease may involve severe movement difficulties, swallowing problems, communication changes, cognitive decline, weight loss, and increasing dependence on caregivers for daily activities. Patients may spend more time in bed or require extensive assistance with meals, hygiene, mobility, and medication routines. During this stage, symptom management often focuses heavily on comfort, dignity, safety, and reducing distress. Families may face difficult emotional and medical decisions while balancing alertness, nutrition, communication ability, and overall quality of life as neurological decline progresses.

20.2 Comfort-focused care and palliative support

Some families discuss cannabis during advanced Huntington’s disease because they hope certain products may help improve relaxation, appetite, sleep, emotional comfort, or physical tension. Cannabis may become part of broader palliative or comfort-focused care discussions alongside standard medical support. Families often focus on concerns such as:

• Physical discomfort and muscle tension
• Sleep disruption and nighttime restlessness
• Anxiety or emotional distress
• Appetite and calorie intake
• Overall comfort and quality of life

Care decisions during advanced disease are highly individualized and often require close caregiver involvement and ongoing medical guidance.

20.3 Monitoring sedation and responsiveness

Advanced Huntington’s disease patients may already experience fatigue, slowed responsiveness, or swallowing difficulties before cannabis is introduced. Because of this, caregivers and healthcare providers often monitor sedation levels carefully when cannabis products are used regularly. Excessive drowsiness, worsening confusion, reduced responsiveness during meals, or increasing fall risk may signal the need for product or dosing adjustments. Responsible cannabis use in advanced disease focuses on maintaining comfort while still protecting safety, communication ability, and overall well-being as much as possible.

21. Caregiver Guidance and Support

21.1 Helping patients use cannabis safely

Caregivers often play a major role in helping Huntington’s disease patients manage medications, meals, appointments, and daily routines. When cannabis becomes part of symptom support, caregivers may also help organize dosing schedules, monitor product use, and observe changes involving movement, mood, sleep, or appetite over time. Many families find that structure and consistency help reduce confusion and improve safety. Keeping products clearly labeled, storing cannabis securely, and tracking symptom response may help patients use cannabis more comfortably and responsibly. Caregivers should focus on support and communication rather than on control, especially during the early stages when patients still maintain significant independence.

21.2 Watching for concerning symptoms

Because Huntington’s disease affects movement, cognition, emotional regulation, and swallowing, caregivers should monitor for symptoms that may require medical attention or adjustments to products. Cannabis may support comfort for some individuals, but sudden changes in alertness or coordination still deserve attention. Caregivers often watch closely for concerns such as:

• Falls or worsening balance problems
• Excessive sedation or confusion
• Choking, coughing, or swallowing difficulties
• Severe anxiety or emotional instability
• Missed medications or reduced daily functioning

Recognizing these warning signs early may help families make safer decisions and prevent complications before they become more serious.

21.3 Preventing caregiver burnout

Caregiving for someone with Huntington’s disease may become emotionally and physically exhausting over time, especially as symptoms progress and independence declines. Many caregivers experience chronic stress, poor sleep, emotional isolation, financial strain, or feelings of guilt when trying to manage responsibilities alone. Caregiver well-being matters just as much as patient support. Families often benefit from respite care, counseling, support groups, trusted friends, and structured breaks that allow caregivers time to rest and recover. Long-term caregiving becomes more sustainable when support systems are built early rather than waiting until exhaustion becomes overwhelming.

22. Mental Health, Depression, and Suicide Risk

22.1 Emotional health in Huntington’s disease

Depression, hopelessness, anxiety, and emotional instability are common in Huntington’s disease and may develop because of both neurological changes and the emotional stress of living with a progressive condition. Patients may struggle with fear about the future, changing independence, family concerns, or frustration related to worsening symptoms. Emotional symptoms should always be taken seriously and never dismissed as weakness or a negative attitude. Early emotional support, counseling, psychiatric care, and strong communication within families may help reduce isolation and improve overall quality of life as symptoms evolve.

22.2 Cannabis and mental health risk

Some Huntington’s disease patients report that carefully selected cannabis products help them feel calmer, sleep more comfortably, or reduce emotional tension during stressful periods. However, stronger THC products may occasionally worsen anxiety, paranoia, emotional instability, or confusion in sensitive individuals. Patients and caregivers should pay attention to factors such as:

• Sudden emotional withdrawal
• Increased hopelessness or panic
• Worsening irritability or paranoia
• Excessive sedation or confusion
• Reduced focus on medical care or safety

Responsible cannabis use involves monitoring emotional well-being honestly and adjusting products carefully when symptoms change.

22.3 When to seek urgent psychiatric help

Families should seek immediate professional support if a patient expresses suicidal thoughts, severe hopelessness, dangerous, impulsive behavior, hallucinations, or significant psychiatric instability. Sudden emotional or behavioral changes may require urgent medical evaluation regardless of whether cannabis is being used. Patients living with Huntington’s disease deserve compassionate psychiatric support and should never feel ashamed for needing mental health care. Early intervention may help improve safety, emotional stability, and overall support for both patients and caregivers.

23. Legal, Driving, and Workplace Considerations

23.1 Medical cannabis laws vary by location

Medical cannabis laws differ widely depending on state and local regulations. Some states allow Huntington’s disease patients to qualify for medical cannabis programs directly, while others may approve cannabis for related symptoms such as chronic pain, muscle spasms, or severe anxiety. Registration requirements, possession limits, and product availability also vary significantly between locations. Patients and caregivers should review local laws carefully before purchasing or traveling with cannabis products. Legal access may still require physician certification, state registration, and purchasing through licensed dispensaries. Understanding regulations early may help families avoid unnecessary stress or confusion during treatment planning.

23.2 Driving and machinery safety

Huntington’s disease already affects coordination, reaction time, judgment, and movement control, which means cannabis related impairment may increase safety risks further in certain patients. Even lower THC doses may affect driving ability differently depending on symptom severity, fatigue, medication use, and overall health. Patients and caregivers often discuss concerns such as:

• Slower reaction time while driving
• Worsening balance or coordination
• Difficulty concentrating during traffic situations
• Delayed responses after edible use
• Increased fall or accident risk

Many families choose to avoid driving after cannabis use entirely, especially as Huntington’s disease symptoms progress over time.

23.3 Employment and disability considerations

Some Huntington’s disease patients continue working during earlier stages of the condition and may worry about medical cannabis policies, workplace disclosure, or drug testing. Legal cannabis use does not always guarantee workplace protection, particularly in safety-sensitive jobs or workplaces with strict testing policies. Patients should review employer policies carefully and discuss disability planning, workplace accommodations, and legal concerns when appropriate. Families often benefit from early financial and long-term planning discussions as Huntington’s disease symptoms gradually affect work capacity and independence.

24. Talking to Your Neurology Team About Cannabis

24.1 Why open communication matters

Patients sometimes hesitate to discuss cannabis with neurologists because they worry about judgment or negative reactions. In reality, honest conversations usually help healthcare professionals provide safer and more informed care. Providers who understand what products patients use can better monitor medication interactions, coordination concerns, sedation, and symptom response over time. Open communication may also help families avoid misinformation from online marketing or unregulated product claims. Huntington’s disease management already involves complex neurological symptoms, so healthcare guidance becomes even more valuable when cannabis is added to the care plan.

24.2 What patients should bring to appointments

Bringing detailed information to appointments may help neurologists and healthcare providers better understand how cannabis affects symptoms and daily functioning. Clear communication often improves safety and allows more realistic conversations about symptom goals and product selection. Helpful things patients and caregivers may bring include:

• Cannabis product labels and dosing information
• Symptom journals or tracking notes
• Updated medication lists
• Notes about sleep, appetite, or mood changes
• Caregiver observations involving safety or coordination

Organized information often makes treatment discussions more productive and easier to follow over time.

24.3 Questions to ask healthcare providers

Patients should feel comfortable asking direct questions about cannabis safety, medication interactions, symptom expectations, and long-term monitoring. Honest conversations help families make more informed decisions rather than relying solely on internet marketing or anecdotal advice. Helpful questions may include whether cannabis could increase sedation, worsen coordination, interfere with medications, or affect cognition differently as Huntington’s disease progresses. Patients may also ask about safer product types, balanced THC and CBD options, and realistic goals involving comfort, sleep, appetite, or emotional well-being.

25. Common Myths About Cannabis and Huntington’s Disease

25.1 “Cannabis cures neurodegenerative disease”

One of the most common misconceptions online is the claim that cannabis can cure Huntington’s disease or fully reverse neurodegenerative damage. Current medical evidence does not support this claim. Cannabis may help support comfort, sleep, appetite, emotional well-being, or quality of life for some patients, but it does not eliminate the genetic mutation or stop disease progression entirely. Families dealing with Huntington’s disease may feel vulnerable to miracle cure marketing because the condition is progressive and emotionally difficult. Reliable cannabis education focuses on symptom support and realistic expectations rather than promising dramatic neurological recovery or genetic repair.

25.2 “CBD is completely risk-free”

Many patients assume CBD products are automatically harmless because they do not usually cause intoxication like THC. While CBD may feel more approachable for some families, it may still interact with medications or contribute to drowsiness in certain individuals. Patients and caregivers should still pay attention to concerns such as:

• Medication interactions
• Excessive sedation or fatigue
• Inaccurate product labeling
• Products containing hidden THC
• Changes in alertness or coordination

Many patients tolerate CBD products well, especially when using regulated products and discussing symptom goals openly with healthcare professionals.

25.3 “Higher THC means stronger medical benefit”

Some cannabis marketing encourages patients to believe that stronger THC products always provide better symptom relief. In reality, higher THC doses may increase dizziness, confusion, sedation, anxiety, or coordination problems without necessarily improving symptom control. Many Huntington’s disease patients report better experiences with lower doses or balanced THC and CBD products that support relaxation and comfort without heavy intoxication. Responsible cannabis use focuses on finding the lowest effective dose that improves quality of life while still maintaining safety and daily functioning.

26. Real-Life Patient and Caregiver Scenarios

26.1 Early-stage patient struggling with anxiety and sleep

An early-stage Huntington’s disease patient may still work, drive, and manage most daily activities independently while struggling with anxiety, stress, nighttime restlessness, or emotional overwhelm after diagnosis. Some patients explore cannabis because they hope certain products may help them relax or improve sleep quality during emotionally difficult periods. In these situations, careful dosing and gradual product introduction often matter greatly. Patients usually benefit from maintaining structure, therapy support, healthy routines, and open communication with healthcare providers while exploring symptom management options responsibly.

26.2 Middle-stage patient with falls and irritability

Middle-stage Huntington’s disease often brings increasing movement symptoms, falls, irritability, frustration, and growing caregiver involvement. Some families explore cannabis because certain products may help support nighttime calmness, appetite, or emotional comfort. Families managing middle-stage symptoms often focus on concerns such as:

• Home safety and fall prevention
• Medication organization
• Monitoring sedation and coordination
• Emotional regulation and caregiver stress
• Consistent routines and supervision

Caregiver involvement becomes increasingly important during this stage because symptom changes may affect judgment, safety awareness, and medication management.

26.3 Advanced-stage patient focused on comfort care

Advanced Huntington’s disease often shifts care priorities toward comfort, dignity, communication support, nutrition, and quality of life. Patients may experience severe mobility limitations, swallowing problems, fatigue, and dependence on caregivers for most daily activities. Some families discuss cannabis as part of broader comfort-focused or palliative care planning, particularly when addressing sleep disruption, emotional distress, appetite concerns, or physical discomfort. During advanced disease, careful monitoring remains essential to balance comfort with alertness, swallowing safety, and overall well-being.

27. Practical Tools and Resources to Use

27.1 Cannabis symptom and dose tracker

Tracking cannabis use may help Huntington’s disease patients and caregivers understand how products affect movement symptoms, sleep, appetite, mood, and daily functioning over time. Simple written records often make it easier to identify patterns, discuss concerns with healthcare providers, and adjust products more safely. Patients and caregivers commonly track information such as product type, THC and CBD content, timing of use, symptom response, and side effects. Monitoring changes consistently may help families recognize whether cannabis is improving comfort and quality of life or creating new concerns involving sedation, confusion, or coordination.

27.2 Caregiver observation checklist

Caregivers often notice subtle symptom changes before patients fully recognize them. Observation checklists may help families monitor safety, swallowing ability, emotional changes, movement symptoms, and medication adherence more consistently as Huntington’s disease progresses. Helpful things caregivers may monitor include:

• Falls or worsening balance problems
• Changes in swallowing or coughing during meals
• Increased confusion or excessive sedation
• Emotional withdrawal or irritability
• Missed medications or disrupted routines

Structured monitoring may help caregivers communicate more clearly with neurologists and improve long-term safety planning.

27.3 Emergency symptom guide

Families affected by Huntington’s disease often feel more prepared when they understand which symptoms deserve urgent medical attention. Emergency guides may help reduce hesitation and improve response times during serious situations involving injury, psychiatric symptoms, or severe neurological decline. Patients and caregivers should seek immediate medical support for choking emergencies, repeated falls with injuries, severe confusion, suicidal thoughts, hallucinations, or major changes in responsiveness. Knowing when to contact the neurologist versus emergency services may help families respond more confidently during stressful situations.

28. Frequently Asked Questions About Medical Cannabis and Huntington’s Disease

Many Huntington’s disease patients and caregivers have practical questions about medical cannabis, especially when balancing movement symptoms, emotional well-being, medication safety, and long-term care planning. These short answers address concerns that families commonly discuss during treatment decisions.

28.1 Can cannabis make Huntington’s movements worse instead of better?

Yes, responses vary greatly between individuals. Some patients report feeling more relaxed or physically comfortable, while others may experience worsening balance, coordination problems, or restlessness with stronger THC products. Careful dosing and gradual product introduction often help families identify which products support comfort without increasing instability or safety concerns.

28.2 Is CBD safer than THC for people with HD?

CBD does not usually cause intoxication like THC, which is why some families feel more comfortable starting with CBD-focused products. However, CBD may still cause drowsiness or interact with medications. Product quality, dose strength, and overall health still matter greatly when deciding whether CBD is a safe fit for symptom management plans.

28.3 Can cannabis help with aggression or severe irritability?

Some patients report that carefully selected cannabis products help reduce stress or emotional tension, but cannabis is not a replacement for psychiatric care or neurological treatment. Severe aggression, emotional instability, paranoia, or unsafe behavior still deserve medical evaluation because symptoms may require broader mental health and medication support.

28.4 What’s the safest cannabis form for someone with swallowing problems?

Many caregivers prefer tinctures, oils, or carefully measured liquid products for patients with dysphagia because they may reduce choking risk compared to hard edibles or dry products. Product choice should always consider swallowing ability, alertness, coordination, and caregiver supervision during meals or medication routines.

28.5 At what stage of Huntington’s disease should cannabis be avoided?

Cannabis decisions become more complex during advanced stages involving severe confusion, repeated falls, psychosis, dangerous swallowing problems, or excessive sedation. Some patients may still use cannabis safely with close caregiver monitoring, while others may require major adjustments or avoidance depending on overall safety, responsiveness, and medical stability.

States Where This Condition Qualifies for Medical Marijuana

Compassionate Huntington’s Disease Support With DocMJ

At DocMJ, we help patients and families explore medical cannabis options for Huntington’s disease symptoms such as sleep disruption, emotional stress, appetite loss, and physical discomfort. We provide medical marijuana evaluations, education, and personalized guidance focused on safe, informed care. Our team supports patients with compassion, clarity, and attention to long-term well-being. Schedule a consultation today!

Citations

1. Humble, J., Schonewille, M., & Steuber, V. (2022). Cannabinoid signaling and risk in Huntington’s disease. Frontiers in Computational Neuroscience, 16, 903947. https://doi.org/10.3389/fncom.2022.903947
2. Kocis, P. T., & Vrana, K. E. (2022). Delta-9-tetrahydrocannabinol and cannabidiol drug drug interactions. Frontiers in Psychiatry, 13, 1055481. https://doi.org/10.3389/fpsyt.2022.1055481
3. National Institute of Neurological Disorders and Stroke. (2023). Huntington’s disease. National Institutes of Health. https://www.ninds.nih.gov/health-information/disorders/huntingtons-disease
4. Ranum, R. M., Whipple, M. O., Croghan, I., Bauer, B., Toussaint, L. L., & Vincent, A. (2023). Use of cannabidiol in the management of insomnia: A systematic review. Cannabis and Cannabinoid Research, 8(2), 213–229. https://doi.org/10.1089/can.2022.0122
5. Saramak, K., & Szejko, N. (2022). Endocannabinoid system as a new therapeutic avenue in Huntington’s disease. IntechOpen. https://www.intechopen.com/chapters/81976
6. Sarris, J., Sinclair, J., Karamacoska, D., Davidson, M., & Firth, J. (2021). Medicinal cannabis for psychiatric disorders: A clinically focused systematic review. Frontiers in Psychiatry, 12, 729800. https://doi.org/10.3389/fpsyt.2021.729800